<?xml version="1.0" encoding="UTF-8"?>
<fn-group>
 <fn fn-type="other">
  <p>
   <bold>Contributors:</bold> TG conceived of the review article and collected the literature. TG, JR, and CHS provided the extraction and interpretation of scientific data and drafted the initial manuscript. JCB assisted with design and scientific review. All authors contributed to manuscript editing, proofread and have approved the final manuscript.
  </p>
 </fn>
 <fn fn-type="other">
  <p>
   <bold>Funding:</bold> The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
  </p>
 </fn>
 <fn fn-type="COI-statement">
  <p>
   <bold>Competing interests:</bold> TG has received speakers and/or advisory board honoraria from BMS, Sanofi-Genzyme, MSD, Novartis Pharma, Roche, Abbvie, Almirall, Janssen, Lilly, Pfizer, Pierre Fabre, Merck-Serono, outside the submitted work. JR and CHS declare that they have no competing interests. JCB is receiving speakerâ€™s bureau honoraria from Amgen, Pfizer, Merck-Serono, Recordati and Sanofi, is a paid consultant/advisory board member for Boehringer Ingelheim, eTheRNA, In ProTher, MerckSerono, Pfizer, 4SC and Sanofi. His group receives research grants from Bristol-Myers Squibb, Merck Serono, HTG, IQVIA, and Alcedis.
  </p>
 </fn>
 <fn fn-type="other">
  <p>
   <bold>Patient consent for publication:</bold> Not required.
  </p>
 </fn>
 <fn fn-type="other">
  <p>
   <bold>Provenance and peer review:</bold> Not commissioned; externally peer reviewed.
  </p>
 </fn>
</fn-group>
